CATX EBITDA Margin
Perspective Therapeutics Inc · EBITDA Margin
CATX EBITDA Margin
Latest reported-31439.07%period ending
CATX EBITDA Margin (-26.22% → -31439.07%)
Annual ebitda margin
High-resolution chart · PNG
CATX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| -4,435.4195% | |
| -2,786.2622% | |
| -156.4912% | |
| -66.1695% | |
| -32.7067% | |
| -35.9091% | |
| -70.3035% | |
| -113.1184% | |
| -129.9937% | |
| 9.8757% | |
| 12.504% | |
| -92.2153% | |
| -73.5308% | |
| -57.5982% | |
| -39.5314% | |
| -57.8057% | |
| 23.7457% | |
| -104.3186% | |
| -156.5795% | |
| -308.5999% | |
| -1,962.3449% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.0245% | |
| -32.558% | |
| -5.5832% | |
| -26.2213% |